Genecast Biotechnology
Healthcare Services · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
903-908 Jiankang Zhigu Bldg 9 no. 35 N H...Phone Number
+86 4000800660Website
www.genecast.com.cnRevenue
$87.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
2
2
About Genecast Biotechnology
Genecast (Beijing) Biotechnology Co. is a privately held leading precision oncology company in China. We offer well validated clinical tests to cancer patients and clinicians based on multiple technology platforms including NGS, IHC, ddPCR, microarray, etc. We are dedicated to providing patients and clinicians individualized cancer diagnosis and treatment to improve their survival and quality of life. In addition, by leveraging our multifaceted technical approach, we actively collaborate with leading domestic and international pharmaceutical and biotech companies to develop and validate oncology biomarkers for clinical trials, treatment and companion diagnosis.Explore more
Genecast Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genecast Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Genecast Biotechnology launches new products
Check out if Genecast Biotechnology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Genecast Biotechnology
Website visits: Recent activity has been detected on your website
Click to see if Genecast Biotechnology had a recent Job posting/layoffs
Genecast Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Genecast Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genecast Biotechnology has new funding data
Earning: See what the market has to say on Genecast Biotechnology recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Genecast Biotechnology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Genecast Biotechnology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Genecast Biotechnology.
Genecast Biotechnology financials insights
Gather financial insights about Genecast Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series B
$19M
2018
Series C
$31M
2019
Series D
$45M
2020
Series E
$149M
Genecast Biotechnology Tech Stack
A closer look at the technologies used by Genecast Biotechnology
See more technologies
Genecast Biotechnology News & Media
Chinese biotech firm Genecast secures $149m in Series E round
The Series E round was led by China Structural Reform Fund, which is anchored by Chinese state-owned assets operator China Chengtong.Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China
Further Strengthens Business Development Team with Key HireInterpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China
PARSIPPANY, NJ, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc.’s subsidiary, Interpace BioPharma Inc. (“Interpace”, “Interpace BioPharma” or the “Company”) today announced that it has entered into a partnership agreement to jointly develop, promote, and offer translational studies and clinical trial solutions to biotech and pharmaceutical companies with Genecast (Beijing) Biotechnology Co. Ltd (“Genecast”) of the Peoples Republic of China (“PRC”). Genecast is a leaderCancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed an exclusive distribution agreement with Genecast Biotechnology to market, distribute and sell the Tissue of Origin® (TOO) Test in China.
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genecast Biotechnology
Sign Up For FreeTo access detailed company insights
Genecast (Beijing) Biotechnology Co. is a privately held leading precision oncology company in China. We offer well validated clinical tests to cancer patients and clinicians based on multiple technology platforms including NGS, IHC, ddPCR, microarray, etc. We are dedicated to providing patients and clinicians individualized cancer diagnosis and tr... Read More
